Cue Biopharma (CUE) EBT Margin Growth (3y) (2021 - 2025)
Cue Biopharma (CUE) EBT Margin Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 6,685.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2,054.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8,006.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,980.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -9,922.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,363.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -5,319.00 |
| 10 | Cue Biopharma | 152.56 Mn | 135.14 Mn | - | -17,405.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 5.06 Mn |
| Mar 31, 2025 | -241,682.00 |
| Dec 31, 2024 | -48,725.00 |
| Sep 30, 2024 | 30,844.00 |
| Jun 30, 2024 | -21,334.00 |
| Mar 31, 2024 | 11,681.00 |
| Dec 31, 2023 | 156,957.00 |
| Sep 30, 2023 | 84,733.00 |
| Jun 30, 2023 | 2,951.00 |
| Mar 31, 2023 | -575,722.00 |
| Dec 31, 2022 | -913,816.00 |
| Sep 30, 2022 | -1.57 Mn |
| Jun 30, 2022 | -5.03 Mn |
| Mar 31, 2022 | 204,211.00 |
| Dec 31, 2021 | 317,001.00 |
| Sep 30, 2021 | 219,990.00 |
| Jun 30, 2021 | 386,803.00 |